2024 Partners
Expertise Partner
Alloy Therapeutics
Keyway TCR Discovery is a proprietary, integrated, end-to-end service for generating highly-specific therapeutically-optimized TCR mimic leads. From immunizing our industry-leading ATX-Gx mice with high-quality protein-HLA complexes, to pairing in vitro and AI/ML capabilities for broad developability and specificity screening, to state-of-art engineering and bespoke functional screening capabilities, Keyway TCR Discovery creates leads you can develop with confidence.
Exhibition Partners
Alithea Biotechnology GmbH
Alithea Biotechnology GmbH (GER) is providing cutting-edge HLA peptidomics technologies for target discovery, validation and off-target toxicity profiling since 2019. Alithea has a web-accessible quantitative HLA peptide database, HLA-Compass, allowing to navigate peptide presentation in health and cancer. Proprietary HLA peptide binding predictors and strong experience in the quantification of HLA ligands together with most sensitive timsToF Ultra-powered mass spectrometry equipment facilitate high quality and sensitivity. Proteogenomics capabilities and an in-house repository of HLA typed tissue samples facilitate rapid validation of hypotheses for TCR/TCRm drug discovery. Alithea happily supports you in solving RnD challenges from target discovery to IND submission.
OmniAb
At the heart of the OmniAb platform is the Biological Intelligence™ including OmniRat®, OmniChicken® and OmniMouse® that have been genetically modified to generate antibodies with human sequences. OmniFlic® (transgenic rat) and OmniClic® (transgenic chicken) address industry needs for bispecific antibody applications, and OmniTaur™ features unique structural attributes of cow antibodies for complex targets. OmnidAb ™ is an in vivo platform for single domain antibodies based upon a human VH scaffold. These proprietary technologies are joined with OmniDeep™, which is a suite of in silico tools. Additionally, an established core competency focused on ion channels and transporters further differentiates OmniAb’s technology.